Home / Intelligence / Podcasts / Capitalizing on Opportunities to Drive Impact in Commercial Operations
In the wake of the COVID-19 pandemic, pharmaceutical companies have needed to pivot in the way they operate so that they can keep information flowing to providers and patients. Commercial Operations functions have since been capitalizing on opportunities to enhance their capabilities and drive impact across their organizations.
Host and Executive Commercial Operations Leader, Ken McDermott, joins a panel of three experts from TGaS Advisors, a division of Trinity Life Sciences, to discuss the shifting priorities as commercial teams work to evolve virtual and digital channels to engage with customers and sharpen advanced analytics.
Featuring:
HOST: Ken McDermott
Executive Commercial Operations Leader
Lisa Klein
Vice President,
Field Operations
Jerry Luciano
Vice President,
Digital and Omnichannel Solutions
Steve Laux
Vice President,
Commercial Insights and Advanced Analytics Solutions
Download the Advisory Brief: Read Trinity Life Sciences’ advisory brief ‘Capitalizing on Opportunities to Drive Impact in Commercial Operations’ to understand the data behind the insights based on Trinity’s work with 2000+ individuals across 300 partner companies, and the key themes that emerged during our 2022 Spring Virtual Client Summit.
Related Intelligence
Analyst Reports
Trinity Life Sciences Secures Prestigious Leader Position in Everest Group’s 2025 PEAK Matrix® for Life Sciences AI & Analytics Excellence
Trinity Life Sciences is a Leader in Everest Group’s 2025 Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment—with its distinction rooted in exceptional, tangible outcomes delivered for clients across the life sciences sector.
Read More
Briefs
2025 Annual State of Learning & Development in Life Sciences
Through the 2020s, life sciences leaders have dealt with one challenge after another. The shock of the COVID-19 pandemic. Sticky inflation. Return-to-office mandates. The intense pressure to perform in the face of disruptive challenges has proven constant. For commercial learning and development, also known as commercial L&D, this has presented new roadblocks and innovations alike, […]
Read More
Briefs
Leading the Evolution: Navigating AI and Pharma Market Trends
How are Commercial, Medical and Market Access organizations evolving to develop capabilities and accelerate innovation in 2025 and beyond? Executive leaders are focused on making informed organizational decisions to propel the evolution of capabilities in this rapidly changing global economy. As you strategize to optimize structure, talent and capabilities to excel in the future, this Advisory Brief brings you critical insights gleaned from the recent TGaS Advisors’ 2025 Spring Summit.
Read More